| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sonoma Pharmaceuticals, Inc. (SNOA) has 6 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. SNOA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 42.2K | $51.0K | - | |
| CFO | 34.4K | $41.6K | - | |
| Other | 25.3K | $30.6K | - | |
| ? | 20.0K | $24.2K | - | |
| ? | 20.0K | $24.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2017 | Schutz James J | Chief Executive Officer | Buy | 929 | $5.46 | $5,069.46 | +6.5% | |
| Mar 9, 2017 | Miller Robert E | Chief Financial Officer | Buy | 750 | $7.02 | $5,267.50 | +3.1% | |
| Mar 8, 2017 | Miller Robert E | Chief Financial Officer | Buy | 1,000 | $6.93 | $6,930.00 | +7.3% | |
| Mar 6, 2017 | Umscheid Marc | Chief Strategy/ Mkt Officer | Buy | 750 | $6.82 | $5,115.00 | New | |
| Mar 3, 2017 | Schutz James J | Chief Executive Officer | Buy | 800 | $6.78 | $5,420.88 | +3.5% | |
| Dec 8, 2016 | Miller Robert E | Chief Financial Officer | Buy | 5,000 | $4.86 | $24,300.00 | +291.7% | |
| Dec 8, 2016 | Schutz James J | Chief Executive Officer | Buy | 1,000 | $4.88 | $4,880.00 | +10.0% | |
| Aug 15, 2016 | Schutz James J | Chief Executive Officer | Buy | 1,328 | $3.66 | $4,865.66 | +25.7% | |
| Feb 25, 2016 | Schutz James J | Chief Executive Officer | Buy | 5,000 | $1.00 | $4,999.50 | +23.9% |